Title for MeetingAbstracts
Alphabetical listing of titles
-
Antigenicity and immunogenicity of HIV-1 envelope glycoproteins derived either from primary isolates or T-cell line adapted strains.
-
Antigenicity of a Recombinant Envelope Glycoprotein Derived from a Primary Isolate of HIV-1 Collected during Primary Infection.
-
Antigenicity of HIV-1 envelope glycoproteins from either primary isolates or T-cell lines adapted strains expressed using a Semliki Forest virus vector.
-
Antigenicity of HIV-1-like Gag-V3 chimeric particles expressed by a recombinant vaccinia virus system.
-
Antigens and antibodies for HIV type 1 in serum, saliva and gingival fluid in patients with advanced disease.
-
Antigens of cryptosporidium parvum recognized by immune sera and saliva from HIV infected individuals.
-
Antigonococcal Activity of Gemifloxacin (LB20304, SB-265805) Using Fluoroquinolone-Resistant Strains and Developing In Vitro Susceptibility Test Methods and Quality Control Guidelines.
-
Antiherpes virus treatment and risk of Kaposi's sarcoma in HIV infection.
-
Antihypertensive agent moxonidine enhances glucose transport in insulin-resistant muscle.
-
Antileukocyte antibodies as a consequence of HIV infection in HIV+ individuals.
-
Antimicrobial Activities of Rifalazil, Levofloxacin, and Clarithromycin against Mycobacterium Tuberculosis and M. avium Complex Replicating in 7HSF Medium or in Macrophages.
-
Antimicrobial Activity and In Vitro Test Development for Cefditoren (CDTR) against Streptococci, H. influenzae (HFLU), and M. catarrhalis (MCAT) Isolated in 1998-99.
-
Antimicrobial Activity and Spectrum of Sitafloxacin (DU-6859a) Tested against S. pneumoniae, viridans Group and Beta-Haemolytic Streptococci: Assessment of Contemporary Strains with Susceptibility Test Development and Quality Control (QC) Guidelines.
-
Antimicrobial Activity of ABT-492 and Tentative Disk Test Interpretive Criteria.
-
Antimicrobial Activity of BMS 284756 (BMS), A New Desfluoroquinolone, Tested Against S. pneumoniae (SPN), H. influenzae (HI), and M. catarrhalis (MCAT) Isolates for SENTRY Antimicrobial Surveillance Program (Latin America, 1999).
-
Antimicrobial Activity of Daptomycin Tested against 6,737 Gram-Positive Strains Collected from Three Continents in 2002.
-
Antimicrobial Activity of Glucoprotamine: a Clinical Study of a New Disinfectant.
-
Antimicrobial Activity of LB11058 Tested against S. pneumoniae, H. influenzae and M. catarrhalis.
-
Antimicrobial Activity of LB11058, a Novel Cephalosporin, Tested against Staphylococci, Streptococci and Enterococci.
-
Antimicrobial Activity of Lentivirus Lytic Peptide Derivatives in Cystic Fibrosis Airway Infection and Septic Arthritis.
-
Antimicrobial Activity of Linezolid (U-100766) Tested against 7,599 Recent Clinical Isolates from Over 50 Medical Center Laboratories.
-
Antimicrobial Activity of Linezolid Tested against Beta-haemolytic Streptococci Isolated from 110 French Hospitals (ColBVH).
-
Antimicrobial Activity of Novel 1,3,4-Thiadiazole, 1,3,4-Oxadiazole, and Benzimidazole Phenyloxazolidinones.
-
Antimicrobial Activity of Novel Azabicyclo[3.1.0]hexyl Phenyloxazolidinones.
-
Antimicrobial Activity of Rifalazil[TM] for Chlamydia pneumoniae.
-
Antimicrobial Activity of Spectrum for Six Broad-Spectrum Beta-Lactams Tested against Pathogens from the Philippines: Report of a Nine-Medical-Center Study in 1998.
-
Antimicrobial Activity of the N Terminal Peptide of Human Lactoferrin hLF(11) against Infections with Multi Drug Resistant Acinetobacter baumannii Strains.
-
Antimicrobial Activity of the Novel Glycylcycline, GAR-936, Tested against Over 1000 Recent Clinical Isolates Including Multiresistant Gram-Positive Cocci.
-
Antimicrobial Agent Susceptibility of Clinical Neisseria meningitidis Isolates from England and Wales.
-
Antimicrobial Agent Susceptibility of Lactobacillus crispatus, L. jensenii, L. gasseri, and other Lactobacillus Species.